Platform Specialty Products Corp. PAH 深 滬
等待開盤 12-18 09:30:00 美东时间
11.24
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 11.24
- 總市值 34.14亿
- 52周最高 13.54
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 9.09
- 委 比 0.00%
- 總股本 3.04亿
- 歷史最高 28.95
- 量 比 0
- 振 幅 0.00%
- 歷史最低 5.25
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Earnings Outlook For Agios Pharmaceuticals
Agios Pharmaceuticals (NASDAQ:AGIO) is gearing up to announce its quarterly ear...
10-30 03:02
Palomar Holdings, Inc. Announces Third Quarter 2025 Financial Results Release Date and Conference Call
Palomar Holdings announced its third quarter 2025 earnings release on November 6, 2025, followed by a conference call on November 7. Investors can join the call via dial-in numbers or webcast. A replay is available from November 7 to 14. Palomar is a specialty insurer with subsidiaries ratings from A.M. Best.
10-28 20:15
FDA Expands Approval of Merck's WINREVAIR After Study Shows 76% Drop in PAH Death and Hospitalization Risk
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S. product label based on the Phase 3 ZENITH trial for
10-27 18:47
'No Place Is Risk-Free Until The World Is Polio-Free:' Bill Gates Urges Global Action To Close Deadly Immunity Gaps
Polio cases drop 99.9%, but funding shortfall could undo progress. Last mile hardest as virus exploits immunity gaps.
10-19 15:37
Roche, Eli Lilly Alzheimer's blood diagnostic test wins FDA approval
The U.S. FDA has approved Elecsys pTau181, a blood-based biomarker test developed by Roche (OTCQX:RHHBY) and Eli Lilly (NYSE:LLY) that can provide an initial assessment for Alzheimer's disease and cog...
10-14 04:41
比尔・盖茨与泛美卫生组织探讨向低收入国家提供减肥药的方案
全球卫生领域相关人士透露，比尔・盖茨与泛美卫生组织（PAHO）均有意推动诺和诺德的 “Wegovy”、礼来的 “ Mounjaro ” 等减肥药在低收入国家...
10-12 05:43
Bill Gates And PAHO Push To Make Weight-Loss Drugs Accessible In Low-Income Nations
Bill Gates and PAHO are working to make weight-loss drugs like Wegovy and Mounjaro more affordable for low-income countries.
10-11 01:58
仿制药厂的新机遇？比尔·盖茨称正探讨将减肥药引入低收入国家
①比尔·盖茨称正筹划大幅降低GLP-1减肥药的价格，以帮助低收入国家应对肥胖的公共健康危机； ②与此同时，泛美卫生组织也在筹划通过基金集采方式，与药企及仿制药商谈判，以扩大药物可及性。
10-11 01:42
Novo Nordisk said to be closing its cell therapy unit
Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...
10-11 00:34
长风药业：国产替代叠加需求爆发，有望在吸入式制剂领域复刻英伟达与比亚迪的投资逻辑与叙事模型
（来源：蚌埠新闻网） 转自：蚌埠新闻网 2025年9月26日，长风药业股份有限公司正式启动全球公开发售，计划发行约4119.8万股H股，发售价定为每股14.7...
10-09 11:21
